Inhibitory KIRs decrease HLA class II-mediated protection in Type 1 Diabetes.
Mora-Bitria L, Debebe BJ, Miners KL, Ladell K, Kaur C, Traherne JA, Jiang W, Price DA, Hadcocks L, McQuibban NAR, Trowsdale J, Wong FS, Pontikos N, Niederalt C, Asquith B.
Mora-Bitria L, et al. Among authors: wong fs.
PLoS Genet. 2024 Dec 26;20(12):e1011456. doi: 10.1371/journal.pgen.1011456. Online ahead of print.
PLoS Genet. 2024.
PMID: 39724143
Free article.